Accelerate Diagnostics, CDC team up against Ebola, other bio threats

Accelerate Diagnostics and the Centers for Disease Control and Prevention said they would collaborate on researching methods to detect biological threats more quickly.

With the recent outbreak of Ebola in Africa, concerns over the length of time required to get virus test results have led to this partnership. Diseases that are candidates for biological terrorism include anthrax, tularemia, and the Ebola and Marburg viruses.

The company said it is developing a platform to provide results in hours rather than days. Early detection in all of these cases would prove to be vital in stopping an outbreak.

At the CDC laboratory, the company's researchers will bring their detection expertise. Using the biological make-up information from the CDC, researchers hope to develop the detection systems for multiple biological threats.

"Early detection of highly infectious bacteria, including bio-threat agents, and determination of their susceptibility to specific antibiotics, is essential for patient management and protection of public health," Accelerate Diagnostics CEO Larry Mehren said. "We are honored and highly motivated to be working with the CDC on this critical public health and national security project."

Organizations in this Story

Accelerate Diagnostics U.S. Centers for Disease Control and Prevention

Want to get notified whenever we write about any of these organizations ?
Next time we write about any of these organizations, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.